7-PHENYLETHLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS

A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDHl or IDH2 mutant cancer and having the structure:

Saved in:
Bibliographic Details
Main Authors BURKHOLDER, Timothy Paul, RANKOVIC, Zoran, BOULET, Serge Louis, BAUER, Renato Alejandro, HAHN, Patric James, GILMOUR, Raymond
Format Patent
LanguageEnglish
Published 13.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDHl or IDH2 mutant cancer and having the structure:
Bibliography:Application Number: MY2019PI03350